Use access key #2 to skip to page content.

Align Technology, Inc. - Value Alert



June 26, 2013 – Comments (0) | RELATED TICKERS: ALGN

Texas (June 26, 2013) Wax Ink has issued a No Investment Interest rating for Align Technology, Inc. (Nasdaq: ALGN) based on a recent baseline equity review which placed fair value between $31-$37.

The recent close of $35.41 is approximately 92% above the fair value buy target for the stock and approximately 7% below the fair value close target for the stock. The recent close is also 9% below analysts’ twelve-month $39.00 median price target for the stock.

The recent close represents a 0% increase in price since the last baseline equity review was conducted in June of 2013.

The stock currently has a trailing twelve-month PE Ratio of 26, and a PEG Ratio of 1.4 basis estimated forward earnings growth of 18%.

In the past 52 weeks, share prices have moved between a high of $39.2 and a low of $23.45, placing equilibrium at $33.42.

Basis the recent close, the stock is trading 13% below the 52 week high, 34% above the 52 week low, 6% above equilibrium, and has an average daily trading volume of approximately 908,000 shares.

Align Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services that are used in dentistry, orthodontics, and dental records storage.

The company's competitors include 3M Company, DENTSPLY International Inc., and Sybron Dental Specialties, Inc..

Financial information that may be contained herein, is based on the company's most recent annual SEC filing for year ending December 31, 2012. All prices are per share unless otherwise noted.

Wax Ink currently has no investment position in the company mentioned in this alert.

Wax Ink is a baseline equity research company comprised of individual investors, NOT licensed or registered with ANY government agency.

For use by Accredited Investors as defined under Title 17, CFR §230.500, Regulation D

0 Comments – Post Your Own

Featured Broker Partners